Business Description
MeiraGTx Holdings PLC
ISIN : KYG596651029
Total Employee Number:
409Description
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.82 | |||||
Equity-to-Asset | -0.24 | |||||
Debt-to-Equity | -1.51 | |||||
Debt-to-EBITDA | -0.91 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -4.12 | |||||
Beneish M-Score | -3.76 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 42.2 | |||||
3-Year EBITDA Growth Rate | 24.4 | |||||
3-Year EPS without NRI Growth Rate | 18.5 | |||||
3-Year FCF Growth Rate | 37.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -8.32 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 91.98 | |||||
9-Day RSI | 86.57 | |||||
14-Day RSI | 80.49 | |||||
3-1 Month Momentum % | 22.3 | |||||
6-1 Month Momentum % | 38.17 | |||||
12-1 Month Momentum % | 67.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.41 | |||||
Days Inventory | 43.38 | |||||
Days Sales Outstanding | 11.1 | |||||
Days Payable | 1876.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.7 | |||||
Shareholder Yield % | -0.64 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 95.41 | |||||
Operating Margin % | -131.89 | |||||
Net Margin % | -151.12 | |||||
EBITDA Margin % | -120.36 | |||||
FCF Margin % | 3.81 | |||||
OCF Margin % | 9.86 | |||||
ROA % | -54.72 | |||||
ROIC % | -46.54 | |||||
3-Year ROIIC % | 22.61 | |||||
ROC (Joel Greenblatt) % | -77.72 | |||||
ROCE % | -99.78 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 99.33 | |||||
PS Ratio | 13.01 | |||||
Price-to-Free-Cash-Flow | 336.84 | |||||
Price-to-Operating-Cash-Flow | 130.61 | |||||
EV-to-EBIT | -11.07 | |||||
EV-to-EBITDA | -12.51 | |||||
EV-to-Revenue | 15.06 | |||||
EV-to-Forward-Revenue | 381.82 | |||||
EV-to-FCF | 343.75 | |||||
Price-to-GF-Value | 0.54 | |||||
Earnings Yield (Greenblatt) % | -9.03 | |||||
FCF Yield % | 0.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MeiraGTx Holdings PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 68.163 | ||
| EPS (TTM) (€) | -1.275 | ||
| Beta | 0.6581 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 0.69 | ||
| Volatility % | 41.4 | ||
| 14-Day RSI | 80.49 | ||
| 14-Day ATR (€) | 0.314101 | ||
| 20-Day SMA (€) | 9.125 | ||
| 12-1 Month Momentum % | 67.59 | ||
| 52-Week Range (€) | 5.4 - 11.7 | ||
| Shares Outstanding (Mil) | 92.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MeiraGTx Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MeiraGTx Holdings PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 134 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 43 days | ||
| General meeting for 2026 | 2026-06-11 10:00 | 7.85 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-20 | 7.90 (+0.00%) | ||
| Annual report for 2025 | 2026-03-30 | 6.45 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-26 | 6.30 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 7.90 (+4.64%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 6.75 (+0.00%) | ||
| General meeting for 2025 | 2025-06-12 10:00 | 5.85 (+0.00%) | ||
| 46th Annual Goldman Sachs Global Healthcare Conference | 2025-06-09 10:00 | 4.70 (+0.00%) |
Show
Entries
MeiraGTx Holdings PLC Frequently Asked Questions
What is MeiraGTx Holdings PLC(FRA:328)'s stock price today?
The current price of FRA:328 is €11.70. The 52 week high of FRA:328 is €11.70 and 52 week low is €5.40.
When is next earnings date of MeiraGTx Holdings PLC(FRA:328)?
The next earnings date of MeiraGTx Holdings PLC(FRA:328) is 2026-08-14 Est..
Does MeiraGTx Holdings PLC(FRA:328) pay dividends? If so, how much?
MeiraGTx Holdings PLC(FRA:328) does not pay dividend.
Press Release
Articles on MeiraGTx Holdings PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers